Poniard To Presents Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial
Small Cell Lung Cancer Trial
Poniard Pharmaceuticals announced that data from a Phase 2 trial of picoplatin in patients with small cell lung cancer will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology.
Details are as follows:
-- Abstract #7722, Poster #EE3